Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production
Open Access
- 19 December 2012
- journal article
- Published by Springer Nature in Virology Journal
- Vol. 9 (1) , 312
Abstract
Recent studies have revealed that Mitochondrial Antiviral Signaling (MAVS) protein plays an essential role in the inhibition of viral infection through type I interferon (IFN) pathway. It has been shown that 3C (pro) cysteine protease of coxsackievirus B3 (CVB3) cleaves MAVS to inhibit type I IFNs induction. Other workers also found that MAVS knock-out mice suffered CVB3 susceptibility and severe histopathological change. Accordingly,our experiments were designed to explore the protection of over-expressing MAVS against CVB3 infection and the possible mechanism.Keywords
This publication has 40 references indexed in Scilit:
- RIG-I/MDA5/MAVS Are Required To Signal a Protective IFN Response in Rotavirus-Infected Intestinal EpitheliumThe Journal of Immunology, 2011
- Interferons at age 50: past, current and future impact on biomedicineNature Reviews Drug Discovery, 2007
- Multiple Functions of the IKK-Related Kinase IKKε in Interferon-Mediated Antiviral ImmunityScience, 2007
- Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription FactorsImmunity, 2006
- Essential role of IPS-1 in innate immune responses against RNA virusesJournal of Experimental Medicine, 2006
- Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirusProceedings of the National Academy of Sciences, 2006
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005
- VISA Is an Adapter Protein Required for Virus-Triggered IFN-β SignalingMolecular Cell, 2005
- Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3Cell, 2005
- IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon inductionNature Immunology, 2005